{"id":"W2950568943","doi":"10.1016/j.ejca.2019.05.020","title":"Prognostic and predictive value of AJCC-8 staging in the phase III EORTC1325/KEYNOTE-054 trial of pembrolizumab vs placebo in resected high-risk stage III melanoma","year":2019,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"EORTC Charitable Trust; European Organisation for Research and Treatment of Cancer; Merck","keywords":"Pembrolizumab; Medicine; Placebo; Stage (stratigraphy); Oncology; Melanoma; Internal medicine; Predictive value; Cancer; Immunotherapy; Pathology; Cancer research; Alternative medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002527941,0.000176903,0.0006141756,0.0003284864,0.00002839824,0.00001614959,0.0002247055,0.00003955331,0.0001834328],"category_scores_gemma":[0.0001880429,0.0001176413,0.0001255522,0.0003837231,0.0001531482,0.0001398604,0.00003897331,0.0005269417,7.148969e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001342765,"about_ca_system_score_gemma":0.0003634863,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005335506,"about_ca_topic_score_gemma":0.00006890413,"domain_scores_codex":[0.9970434,0.0009345619,0.00104975,0.0001869395,0.0005548549,0.000230478],"domain_scores_gemma":[0.998163,0.0003134013,0.001018248,0.0002502453,0.0001855436,0.00006950914],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8905464,0.0007032461,0.06453826,0.000207223,0.0005624463,0.0003322646,0.009133812,0.0003891524,0.01511997,0.0000282196,0.0003848983,0.01805415],"study_design_scores_gemma":[0.5452387,0.01620184,0.4256127,0.002149252,0.0003785898,0.00006905854,0.002283497,0.0006752617,0.004862488,0.00001573647,0.002299784,0.0002129966],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9946205,0.002262244,0.00007086406,0.0003329741,0.0003781518,0.001049327,0.00007241865,0.000004211935,0.001209303],"genre_scores_gemma":[0.9979209,0.001412859,0.00005382147,0.000101036,0.0002323684,0.00000633319,0.000004627173,0.00003098567,0.0002370322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3610745,"threshold_uncertainty_score":0.4797272,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01246053364818094,"score_gpt":0.2876012665329937,"score_spread":0.2751407328848128,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}